165 related articles for article (PubMed ID: 10234876)
1. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases.
Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G
Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876
[TBL] [Abstract][Full Text] [Related]
2. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
3. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
Dickerhoff R; von Ruecker A
J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
[TBL] [Abstract][Full Text] [Related]
4. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
5. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
6. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
O'Brien SH; Ritchey AK; Smith KJ
Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic thrombocytopenic purpura (ITP) in children.
Baronci C; Pansini V; Funaro D; Coletti V; Caruso R; De Rossi G
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):665-7. PubMed ID: 16933259
[TBL] [Abstract][Full Text] [Related]
10. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
Masłowska E; Wysocki M; Michalak-Nowaczyk A
Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
[TBL] [Abstract][Full Text] [Related]
12. Childhood acute immune thrombocytopenic purpura: 20 years later.
Blanchette VS; Carcao M
Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune thrombocytopenias].
Lefrère F
Rev Prat; 2001 Sep; 51(14):1558-63. PubMed ID: 11757272
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
Duru F; Fisgin T; Yarali N; Kara A
Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count.
Khellaf M; Michel M; Schaeffer A; Bierling P; Godeau B
Haematologica; 2005 Jun; 90(6):829-32. PubMed ID: 15951296
[TBL] [Abstract][Full Text] [Related]
18. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
19. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
20. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]